Cargando…
Response to R. Waldman et al.: ‘Does IL‐4 inhibition play a role in dupilumab‐associated conjunctivitis?’
Linked Article: Waldman et al. Br J Dermatol 2020; 182:251. Bakker et al. Br J Dermatol 2019; 180:1248–9.
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317488/ https://www.ncbi.nlm.nih.gov/pubmed/31853960 http://dx.doi.org/10.1111/bjd.18808 |
| _version_ | 1783550639402385408 |
|---|---|
| author | Ardeleanu, M. Shumel, B. Rossi, A.B. Graham, N.M.H. |
| author_facet | Ardeleanu, M. Shumel, B. Rossi, A.B. Graham, N.M.H. |
| author_sort | Ardeleanu, M. |
| collection | PubMed |
| description | Linked Article: Waldman et al. Br J Dermatol 2020; 182:251. Bakker et al. Br J Dermatol 2019; 180:1248–9. |
| format | Online Article Text |
| id | pubmed-7317488 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73174882020-06-30 Response to R. Waldman et al.: ‘Does IL‐4 inhibition play a role in dupilumab‐associated conjunctivitis?’ Ardeleanu, M. Shumel, B. Rossi, A.B. Graham, N.M.H. Br J Dermatol Letters to the Editor Linked Article: Waldman et al. Br J Dermatol 2020; 182:251. Bakker et al. Br J Dermatol 2019; 180:1248–9. John Wiley and Sons Inc. 2020-02-09 2020-05 /pmc/articles/PMC7317488/ /pubmed/31853960 http://dx.doi.org/10.1111/bjd.18808 Text en © 2019 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letters to the Editor Ardeleanu, M. Shumel, B. Rossi, A.B. Graham, N.M.H. Response to R. Waldman et al.: ‘Does IL‐4 inhibition play a role in dupilumab‐associated conjunctivitis?’ |
| title | Response to R. Waldman et al.: ‘Does IL‐4 inhibition play a role in dupilumab‐associated conjunctivitis?’ |
| title_full | Response to R. Waldman et al.: ‘Does IL‐4 inhibition play a role in dupilumab‐associated conjunctivitis?’ |
| title_fullStr | Response to R. Waldman et al.: ‘Does IL‐4 inhibition play a role in dupilumab‐associated conjunctivitis?’ |
| title_full_unstemmed | Response to R. Waldman et al.: ‘Does IL‐4 inhibition play a role in dupilumab‐associated conjunctivitis?’ |
| title_short | Response to R. Waldman et al.: ‘Does IL‐4 inhibition play a role in dupilumab‐associated conjunctivitis?’ |
| title_sort | response to r. waldman et al.: ‘does il‐4 inhibition play a role in dupilumab‐associated conjunctivitis?’ |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317488/ https://www.ncbi.nlm.nih.gov/pubmed/31853960 http://dx.doi.org/10.1111/bjd.18808 |
| work_keys_str_mv | AT ardeleanum responsetorwaldmanetaldoesil4inhibitionplayaroleindupilumabassociatedconjunctivitis AT shumelb responsetorwaldmanetaldoesil4inhibitionplayaroleindupilumabassociatedconjunctivitis AT rossiab responsetorwaldmanetaldoesil4inhibitionplayaroleindupilumabassociatedconjunctivitis AT grahamnmh responsetorwaldmanetaldoesil4inhibitionplayaroleindupilumabassociatedconjunctivitis |